[Clinical evaluation of a new gastroenterotrophic, spasmolytic and antacid combination (Gefarmil compositum)].
D000328:Adult; D000368:Aged; D000863:Antacids / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*
D000863:Antacids; D010276:Parasympatholytics; D010879:Piperazines; D008274:Magnesium
Valutazione clinica di una nuova associazione gastroenterotrofica, spasmolitica e antiacida (Gefarnil compositum)